STOCKS TELEGRAPH

Tag: Dare stock

  • Ovaprene Trial Update Boosts Daré Bioscience Market Performance

    Ovaprene Trial Update Boosts Daré Bioscience Market Performance

    Daré Bioscience, Inc. (NASDAQ: DARE) shares surged by 74.16% to $4.38 as of the last check during morning trading following the release of encouraging interim data from a Phase 3 clinical trial.

    Positive Interim Analysis Supports Efficacy and Safety

    The trial evaluates the contraceptive effectiveness, safety, and acceptability of Ovaprene, DARE’s investigational monthly, hormone-free intravaginal contraceptive. Notably, no FDA-approved products currently exist within this contraceptive category, placing Ovaprene in a potentially groundbreaking position.

    The study’s Data Safety Monitoring Board (DSMB) conducted a planned interim review and recommended that the trial continue without any modifications. The interim analysis revealed that approximately 9% of women using Ovaprene experienced pregnancy—aligned with prior expectations and data from the pre-pivotal postcoital test study. The effectiveness of ovaprene as a hormone-free contraception is well supported by these studies.

    Crucially, during the review, no significant safety issues were brought forward. Vaginal odor was the most frequent product-related adverse event, causing almost 17% of participants to stop the research. Overall tolerability remained acceptable in spite of this, and most women who finished the experiment had a high propensity to use Ovaprene if it were made commercially accessible.

    A New Direction for Women’s Health

    Ovaprene has the potential to address a significant unmet need in the contraceptive market, according to Daré Bioscience, which expressed confidence about these findings. The business sees Ovaprene as a potentially game-changing solution in reproductive health, given the rising desire among American women for hormone-free birth control solutions.

    Commercial Prospects with Bayer and Future Milestones

    Commercial momentum may accelerate if Bayer elects to exercise its exclusive U.S. commercialization rights following trial completion. This decision would involve a $20 million payment to Daré Bioscience.

    In total, Daré Bioscience stands to gain up to $310 million in commercial milestone payments, along with double-digit tiered royalties on net sales. These payments are subject to a minority interest provision under a royalty purchase agreement made in April 2024.

  • Dare Bioscience, Inc. (DARE) Stock Rocketing Higher, Here’s the Reason

    Dare Bioscience, Inc. (DARE), a clinical-stage biopharmaceutical company, has soared 37.61% in aftermarket trading session. Consequently, DARE is trading at $2.92 at the time of the writing. On Tuesday, DARE closed the day at $2.12 after surging 10.52% during regular trading hours. The increase in stock could be attributed to the approval of XACIATO by the FDA.

    Why DARE Rising?

    On Tuesday, DARE announced that the Food and Drug Administration (FDA) has approved XACIATO, clindamycin phosphate vaginal gel, 2%, for treating bacterial vaginosis in girls having age 12 years or older. Bacterial vaginosis is among the most common causes of vaginitis around the globe. It is estimated that vaginitis affects about 21 million women in the US alone. The FDA approval of XACIATO comes three years after the company licensed that technology.

    Q3 2021 Operational Results

    On 10th November, DARE released the operational results for the third quarter of fiscal 2021. The quarter ended on 30th September. The company bore total operating expenses of $12.6 million during the quarter against $7.5 million for the same period of 2020. The net loss suffered by the company during the three-month period stood at $12.66 million against $7.5 million for the same period of 2020. The net loss per basic and diluted share for the quarter stood at $0.18 against $0.24 for the same period of 2020.

    Executive Commentary

    While commenting on the results, Sabrina Martucci Johnson, President, and CEO of DARE said that the company has made continued efforts and significant progress on several of the key clinical and strategic corporative initiatives during the quarter. Based on those, the company is gearing up for eventful next few months and looks forward to providing updates as its progress continues in a forward direction.  

    Future Outlook for DARE

    During the last month, DARE stock has jumped up more than 32%. Based on that, analysts are predicting that dare stock should be on the radar of potential investors, who could reap numerous benefits from the stock in the near future.

  • What Explains The 61% Rise In DARE Stock Premarket?

    What Explains The 61% Rise In DARE Stock Premarket?

    Shares of Daré Bioscience Inc. (DARE) were up 61.18% in pre-market trading as of the last check at $2.45. In yesterday’s session, shares of DARE dropped -3.90% at $1.52. DARE stock fluctuated between $1.46 and $1.60 during the day. There were 3.19 million shares traded, which is above DARE’s daily volume of 2.47 million over the last 50 days and its year-to-date volume of 2.55 million.

    Shares of DARE stock have gained 50.50% in the last 12 months, but have declined -9.52% in the last week. For the past six months, DARE stocks have gained 16.03%, and for the past three months, the stock has declined -11.11%. DARE stock’s returns for this year have been 13.43%.  DARE’s stock rose despite no current news, and we can then identify recent developments for a deeper analysis.

    What happened recently at DARE?

    Daré Bioscience develops innovative products for women’s health as a clinical-stage biopharmaceutical company. As part of its mission, DARE brings to market a wide range of differentiated therapies for women debating contraception, vaginal health, sexual health, and fertility.

    The Phase 1 clinical trial of DARE-HRT1 by Daré Bioscience recently reported positive topline results.

    • DARE-HRT1 is a new IVR technology that delivers bio-identical 17-estradiol and bio-identical progesterone continuously for 28 days as part of a hormone therapy (HT) regimen to treat vasomotor symptoms (VMS) and genitourinary syndrome associated with menopause.
    • Two different active pharmaceutical ingredients were successfully delivered by DARE-HRT1 reliably over 28 days.
    • It is a great achievement for Daré and for the IVR platform to generate positive topline data in its first Phase 1 study utilizing novel IVR technology.
    • The use of hormone therapy for some women can relieve symptoms of menopause such as hot flashes and vaginal dryness while also preventing bone loss.
    • The North American Menopause Society’s guidance on hormone therapy includes that dosing estrogen and progestogen in combination may offer important benefits to women and NAMS observed that non-oral routes of administration may offer advantages over orally administered therapies.

    What DARE study has demonstrated?

    Daré Bioscience (DARE) is encouraged by the Phase 1 results since these data demonstrate DARE-HRT1’s ability to meet its dual release objectives. IVR technology played a big role in DARE-HRT1’s success as it provides hormone therapy as well as platform technology. Compared to current vaginal drug delivery solutions, Dare-HRT1’s IVR technology may offer a more flexible and convenient way to deliver drugs to women as it allows them to release one or more drugs at a desired rate over time and at their convenience as well.

  • Market Movers: What changed for these 45 stocks while you were sleeping

    Market Movers: What changed for these 45 stocks while you were sleeping

    Sundial Growers Inc. (SNDL) stock plunged -11.07% to $0.466 in the pre-market trading. The firm recently reported that it filed new shelf registration statement. The most recent rating by CIBC, on August 17, 2020, is a Neutral.
    Obalon Therapeutics Inc. (NASDAQ: OBLN) shares are trading down -10.87% at $2.05 at the time of writing. Company’s 52-week ranged between $0.62 to $2.14. Analysts have a consensus price target of $3.
    Eastman Kodak Company (KODK) stock moved up 7.14 percent to $12.9 in the pre-market trading after the company gets a clean chit from the U.S. government.
    American Airlines Group Inc. (AAL), a Airlines company, rose about 2.03% at $17.56 in pre-market trading Tuesday.
    Zomedica Corp. (ZOM) gained over 2.45% at $0.18 in pre-market trading Tuesday December 08, 2020 after reporting that, with the hiring of Debra Rock to lead the Company’s Marketing Department, its internal commercial leadership team is complete.
    Before the trading started on December 08, 2020, Tesla Inc. (TSLA) is down -0.35% to reach $639.5. It has been trading in a 52-week range of $65.45 to $607.80.
    Nano Dimension Ltd. (NNDM) is up more than 8.55% at $7.24 in pre-market hours Tuesday December 08, 2020 following the declaration of its Pricing $180 million registered direct offering. The stock had dropped over -10.35% to $6.67 in the last trading session.
    Apex Technology Acquisition Corporation (NASDAQ: APXT) shares are trading up 4.31% at $15.25 at the time of writing. Company’s 52-week ranged between $9.13 to $17.25.
    FuelCell Energy Inc. (FCEL) stock soared 2.55% to $8.03 in the pre-market trading. The firm recently reported completion of the previously announced underwritten public offering of 39,696,320 shares of its common stock. The most recent rating by JP Morgan, on November 19, 2020, is a Neutral.
    RMG Acquisition Corp. (RMG) gained over 3.24% at $17.2 in pre-market trading Tuesday December 08, 2020.
    BlackBerry Limited (NYSE: BB) shares are trading up 4.24% at $8.6 at the time of writing. The AI security provider recently declared that it will report results for the third quarter of fiscal year 2021 at 5:30 p.m. ET on Thursday, December 17, 2020. The Company’s 52-week ranged between $2.70 to $9.69.
    Kaixin Auto Holdings (KXIN) is up more than 6.9% at $4.65 in pre-market hours Tuesday December 08, 2020. The stock had dropped over -11.22% to $4.35 in the last trading session.
    XPeng Inc. (XPEV) gained over 2.19% at $49.36 in pre-market trading Tuesday December 08, 2020 after declaring that it intends to offer and sell 40,000,000 American Depositary Shares.
    Ideanomics Inc. (IDEX) is up more than 9.66% at $2.27 in pre-market hours Tuesday December 08, 2020. The stock had jumped over 2.48% to $2.07 in the last trading session.
    HEXO Corp. (HEXO) stock plunged -4.95% to $0.96 in the pre-market trading following the proclamation of downward revision to its proposed share consolidation ratio. The most recent rating by Cantor Fitzgerald, on July 22, 2020, is a Neutral.
    Before the trading started on December 08, 2020, Li Auto Inc. (LI) is up 3.21% to reach $32.5. It has been trading in a 52-week range of $14.31 to $47.70.
    Kandi Technologies Group Inc. (NASDAQ: KNDI) shares are trading up 7.18% at $9.1 at the time of writing. The firm recently issued chairman’s letter to shareholders. Company’s 52-week ranged between $2.17 to $17.45.
    Virgin Galactic Holdings Inc. (SPCE), a Aerospace & Defense company, rose about 6.12% at $35.87 in pre-market trading Tuesday.
    Moderna Inc. (MRNA) grew over 3.44% at $165.01 in pre-market trading today after reporting that Canada exercises increased option for total of 40 million doses of mRNA vaccine candidate against COVID-19 (mRNA-1273).
    Platinum Group Metals Ltd. (PLG) is up more than 17.21% at $4.7 in pre-market hours Tuesday December 08, 2020. The stock had jumped over 29.35% to $4.01 in the last trading session.
    United Microelectronics Corporation (NYSE: UMC) shares are trading up 1.22% at $9.15 at the time of writing following the declaration of its unaudited net sales for the month of November 2020. Company’s 52-week ranged between $2.10 to $8.96.
    Energy Fuels Inc. (UUUU) stock soared 6.32% to $3.03 in the pre-market trading. The most recent rating by Noble Capital Markets, on May 13, 2019, is a Market perform.
    ToughBuilt Industries Inc. (TBLT), a Tools & Accessories company, dropped about -10.84% at $0.7356 in pre-market trading Tuesday after reporting the launch 14 new tool organization SKUs at LOWE’S nationwide.
    IZEA Worldwide Inc. (NASDAQ: IZEA) shares are trading down -6.68% at $0.885 at the time of writing. Company’s 52-week ranged between $0.07 to $3.13.
    Gran Tierra Energy Inc. (GTE) gained over 64.15% at $0.5 in pre-market trading Tuesday December 08, 2020 following the publication of a financial update and the Company’s 2021 capital budget and production guidance.
    Electrameccanica Vehicles Corp. (SOLO) gained over 4.15% at $7.78 in pre-market trading Tuesday December 08, 2020.
    Before the trading started on December 08, 2020, iBio Inc. (IBIO) is down -8.67% to reach $1.37 after revealing an underwritten public offering of its common stock. It has been trading in a 52-week range of $0.19 to $7.45.
    Cinedigm Corp. (CIDM) is down more than -2.34% at $0.671 in pre-market hours Tuesday December 08, 2020. The stock had dropped over -1.63% to $0.69 in the last trading session.
    CBAK Energy Technology Inc. (CBAT), a Electrical Equipment & Parts company, rose about 8.98% at $7.04 in pre-market trading Tuesday after declaring that its wholly owned subsidiary, Dalian CBAK Energy Technology Co., LTD signed a joint development agreement with Wuxi Lead Intelligent Equipment Co., Ltd..
    Before the trading started on December 08, 2020, Torchlight Energy Resources Inc. (TRCH) is up 2.99% to reach $0.69. It has been trading in a 52-week range of $0.21 to $1.09.
    Before the trading started on December 08, 2020, Sumo Logic Inc. (SUMO) is up 5.43% to reach $26.0 after releasing financial results for the third quarter of its fiscal 2021, ended October 31, 2020. It has been trading in a 52-week range of $16.71 to $30.29.
    QEP Resources Inc. (QEP) is up more than 5.63% at $2.25 in pre-market hours Tuesday December 08, 2020. The stock had dropped over -1.39% to $2.13 in the last trading session.
    ON Semiconductor Corporation (NASDAQ: ON) shares are trading up 4.63% at $31.99 at the time of writing. The firm lately revealed that Hassane El-Khoury has been named as the company’s president, chief executive officer and member of its board of directors. Company’s 52-week ranged between $8.17 to $30.04.
    Uranium Energy Corp. (UEC) stock soared 11.89% to $1.6 in the pre-market trading. The most recent rating by Canaccord Genuity, on October 14, 2020, is a Speculative buy.
    Stitch Fix Inc. (SFIX) gained over 33.27% at $47.75 in pre-market trading Tuesday December 08, 2020 following the releaseof its financial results for the first quarter of fiscal year 2021 ended October 31, 2020
    Switchback Energy Acquisition Corporation (SBE) grew over 1.76% at $37.01 in pre-market trading today.
    Stealth BioTherapeutics Corp (MITO) is down more than -1.34% at $1.47 in pre-market hours Tuesday December 08, 2020 after announcing appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors. The stock had jumped over 14.62% to $1.49 in the last trading session.
    Gevo Inc. (GEVO) grew over 3.59% at $1.73 in pre-market trading today.
    Before the trading started on December 08, 2020, Trillium Therapeutics Inc. (TRIL) is down -5.29% to reach $14.51 after presenting at the American Society of Hematology (ASH) Annual Meeting, taking place virtually from December 5-8, 2020. It has been trading in a 52-week range of $0.29 to $20.96.
    Lizhi Inc. (LIZI) stock moved up 2.11 percent to $3.88 in the pre-market trading.
    Dare Bioscience Inc. (DARE) stock soared 5.26% to $1.4 in the pre-market trading after declaring positive topline results from DARE-BVFREE, a Phase 3 trial of DARE-BV1 in patients diagnosed with bacterial vaginosis.
    Top Ships Inc. (TOPS) gained over 6.04% at $1.58 in pre-market trading Tuesday December 08, 2020.
    Westwater Resources Inc. (WWR) grew over 1.37% at $5.94 in pre-market trading today following update on pilot plant operations provided by company.
    InterPrivate Acquisition Corp. (IPV) stock moved up 5.25 percent to $15.03 in the pre-market trading.
    Before the trading started on December 08, 2020, Futu Holdings Limited (FUTU) is up 2.41% to reach $43.31 following the announcement of agreement to purchase shares by a leading global investment firm. It has been trading in a 52-week range of $8.16 to $51.10.

  • Pre-Market Cues: 32 Stocks Roaring for Change On December 1st

    Pre-Market Cues: 32 Stocks Roaring for Change On December 1st

    China Automotive Systems Inc. (CAAS) stock soared 2.38% to $10.75 in the pre-market trading after reporting that it shipped approximately 120,000 units from its portfolio of electric power steering products for use in Chinese electric vehicles during 2020. The most recent rating by Brean Murray, on August 15, 2011, is a Hold.
    Before the trading started on December 01, 2020, G1 Therapeutics Inc. (GTHX) is up 4.05% to reach $19.0. It has been trading in a 52-week range of $8.80 to $31.38.
    Sundial Growers Inc. (NASDAQ: SNDL) shares are trading up 29.83% at $0.947 at the time of writing following the announcement its elimination of senior secured second lien convertible notes. Company’s 52-week ranged between $0.14 to $3.88.
    Jaguar Health Inc. (JAGX) grew over 69.45% at $0.5929 in pre-market trading today.
    SuperCom Ltd. (SPCB) stock moved down -10.74 percent to $1.08 in the pre-market trading and the company recently declared that it has secured a contract to provide its PureSecurity Electronic Monitoring (EM) suite in Wisconsin.
    MicroStrategy Incorporated (NASDAQ: MSTR) shares are trading up 4.93% at $359.66 at the time of writing. Company’s 52-week ranged between $90.00 to $280.00. Analysts have a consensus price target of $200.
    Veritone Inc. (VERI) grew over 4.4% at $27.78 in pre-market trading today after announcing that it now supports NVIDIA CUDA for GPU-based AI and machine learning.
    Before the trading started on December 01, 2020, Creative Realities Inc. (CREX) is down -7.26% to reach $1.15. It has been trading in a 52-week range of $0.52 to $5.98.
    Moderna Inc. (MRNA) stock soared 10.32% to $168.5 in the pre-market trading after declaring that the primary efficacy analysis of the Phase 3 study of mRNA-1273 conducted on 196 cases confirms the high efficacy observed at the first interim analysis. The most recent rating by Wells Fargo, on November 23, 2020, is an Equal weight.
    VBI Vaccines Inc. (VBIV), a Biotechnology company, rose about 3.94% at $3.56 in pre-market trading Tuesday.
    Schultze Special Purpose Acquisition Corp. (SAMA) stock moved up 2.86 percent to $12.6 in the pre-market trading after reporting effectiveness of registration statement for proposed business combination with Clever Leaves International Inc.
    Celsion Corporation (CLSN) gained over 5.59% at $0.71 in pre-market trading Tuesday December 01, 2020.
    Nano-X Imaging Ltd. (NNOX) is up more than 5.22% at $64.5 in pre-market hours Tuesday December 01, 2020. The healthcare firm lately announced revised time of live demonstration at the 2020 radiology society of North America virtual annual meeting. The stock had jumped over 17.21% to $61.30 in the last trading session.
    Before the trading started on December 01, 2020, Greenlane Holdings Inc. (GNLN) is up 2.89% to reach $4.27. It has been trading in a 52-week range of $1.02 to $4.20.
    Mogo Inc. (MOGO) stock soared 3.77% to $2.75 in the pre-market trading. The firm recently declared the release of its new updated Mogo app featuring an interactive Rainforest Mode as part of the MogoCard experience. The most recent rating by Raymond James, on July 23, 2020, is an Outperform.
    Altimmune Inc. (NASDAQ: ALT) shares are trading up 9.57% at $13.4 at the time of writing. Company’s 52-week ranged between $1.60 to $35.10. Analysts have a consensus price target of $28.
    Novavax Inc. (NVAX) grew over 6.09% at $148.0 in pre-market trading today following publication its COVID-19 vaccine clinical development progress.
    Marathon Patent Group Inc. (MARA), a Capital Markets company, rose about 7.96% at $6.78 in pre-market trading Tuesday.
    Aphria Inc. (APHA) is up more than 3.46% at $8.67 in pre-market hours Tuesday December 01, 2020. The healthcare company recently revealed that it has closed the accretive, strategic acquisition of SW Brewing Company, LLC. The stock had jumped over 8.41% to $8.38 in the last trading session.
    AquaBounty Technologies Inc. (AQB) gained over 4.31% at $6.05 in pre-market trading Tuesday December 01, 2020.
    Before the trading started on December 01, 2020, ADMA Biologics Inc. (ADMA) is up 2.45% to reach $2.09 following the announcement its commencement of operations and initiation of collections at its newest ADMA BioCenters plasma collection facility located in Maryville, Tennessee. It has been trading in a 52-week range of $1.45 to $4.95.
    CureVac N.V. (CVAC) is down more than -3.12% at $101.89 in pre-market hours Tuesday December 01, 2020. The stock had jumped over 22.29% to $105.17 in the last trading session.
    OrganiGram Holdings Inc. (OGI) gained over 4.26% at $1.47 in pre-market trading Tuesday December 01, 2020 after releasing its results for the fourth quarter ended August 31, 2020.
    FuelCell Energy Inc. (FCEL) is down more than -3.43% at $9.85 in pre-market hours Tuesday December 01, 2020. The stock had jumped over 5.26% to $10.20 in the last trading session.
    SSR Mining Inc. (SSRM) grew over 2.12% at $18.8 in pre-market trading today. The company lately publicized that positive results of the Çöpler District master plan studies.
    Before the trading started on December 01, 2020, Entasis Therapeutics Holdings Inc. (ETTX) is up 4.35% to reach $1.92. It has been trading in a 52-week range of $1.58 to $5.64.
    Luokung Technology Corp. (LKCO) is up more than 2.93% at $0.6 in pre-market hours Tuesday December 01, 2020 after the firm reported that it won bid for Heilongjiang Institute of Technology (“HIT”) Smart Campus first phase procurement project of USD 1.3 million. The stock had jumped over 4.09% to $0.58 in the last trading session.
    Riot Blockchain Inc. (RIOT) is up more than 3.55% at $8.75 in pre-market hours Tuesday December 01, 2020. The stock had jumped over 35.20% to $8.45 in the last trading session.
    Before the trading started on December 01, 2020, Dada Nexus Limited (DADA) is down -4.28% to reach $55.47 after declaring proposed follow-on public offering of American depositary shares. It has been trading in a 52-week range of $14.60 to $56.91.
    Logitech International S.A. (NASDAQ: LOGI) shares are trading down -3.3% at $87.32 at the time of writing. Company’s 52-week ranged between $31.37 to $95.71.
    Advaxis Inc. (ADXS), a Biotechnology company, rose about 11.86% at $0.33 in pre-market trading Tuesday. The biotechnology firm recently declared closing of $9.2 million public offering.
    Arbutus Biopharma Corporation (NASDAQ: ABUS) shares are trading up 11.26% at $5.04 at the time of writing. Company’s 52-week ranged between $0.88 to $9.02. Analysts have a consensus price target of $8.

  • 30 hot stocks trending in the pre-market session

    Naked Brand Group Limited (NAKD) stock plunged -4.92% to $0.1603 in the pre-market trading.

    Nano Dimension Ltd. (NASDAQ: NNDM)  shares are trading up 11.74% at $4.95 at the time of writing recently announced prices $100 million registered direct offering. Company’s 52-week ranged between $0.51 to $6.00. Analysts have a consensus price target of $8.

    BIO-key International Inc. (BKYI), a Security & Protection Services company, dropped about -6.14% at $2.75 in pre-market trading Monday after company recently announced that the Board of Directors has approved a 1-for-8 reverse stock split that is expected to become effective on November 20, 2020.

    Eiger BioPharmaceuticals Inc. (EIGR) stock moved up 9.67 percent to $11.0 in the pre-market trading following firm recently revealed that the U.S. Food and Drug Administration (FDA) has approved ZokinvyTM (lonafarnib) for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS or Progeria) and processing-deficient Progeroid Laminopathies (PL).

    Lexicon Pharmaceuticals Inc. (LXRX) is down more than -5.33% at $1.42 in pre-market hours Monday November 23, 2020. The stock had dropped over -3.23% to $1.50 in the last trading session.

    Despegar.com Corp. (DESP), a Travel Services company, dropped about -6.54% at $10.01 in pre-market trading Monday.

    Bristol-Myers Squibb Company (BMY) stock moved up 1.41 percent to $62.48 in the pre-market trading today following announcement of  a discovery collaboration with Bristol Myers Squibb Company (NYSE: BMY) to discover, develop, and commercialize therapeutics in multiple disease areas.

    Niu Technologies (NIU) lost over -5.79% at $33.66 in pre-market trading Monday November 23, 2020 as the firm revealed changes to its board of directors and committees of the Board.

    Nxt-ID Inc. (NXTD) is up more than 8.36% at $0.389 in pre-market hours Monday November 23, 2020. The stock had dropped over -0.28% to $0.36 in the last trading session following the corporation said that it plans to adjourn the Annual Meeting of Stockholders, scheduled to be held on Monday, November 23, 2020 at 9:00 a.m. (Eastern Time), to Tuesday, November 24, 2020 at 9:00 a.m. (Eastern Time), to be held at the Company’s office at 288 Christian Street, Hangar C 2nd Floor, Oxford CT 06478.

    Before the trading started on November 23, 2020, Verb Technology Company Inc. (VERB) is up 9.26% to reach $1.18. It has been trading in a 52-week range of $0.78 to $2.64.

    CIIG Merger Corp. (CIIC) stock soared 13.29% to $19.26 in the pre-market trading.

    RedHill Biopharma Ltd. (NASDAQ: RDHL) shares are trading up 8.89% at $9.8 at the time of writing. Company’s 52-week ranged between $3.26 to $11.35 after announced that it has initiated its Phase 3 study to evaluate the safety and efficacy of RHB-204 as a potential first-line, stand-alone, oral treatment of pulmonary nontuberculous mycobacteria (NTM) disease caused by Mycobacterium avium Complex (MAC) – a rare disease for which there is no FDA-approved first-line therapy.

    Xunlei Limited (XNET) gained over 12.0% at $3.08 in pre-market trading Monday November 23, 2020.

    Amarin Corporation plc (AMRN) is down more than -9.74% at $4.17 in pre-market hours Monday November 23, 2020 after shared positive, statistically significant top-line results from Protocol Number EDPC003R01, a Phase 3 clinical trial of VASCEPA® (icosapent ethyl) conducted in China by Amarin partner, Edding. The stock had jumped over 1.76% to $4.62 in the last trading session.

    United Microelectronics Corporation (UMC) grew over 8.65% at $6.28 in pre-market trading today.

    Baozun Inc. (BZUN), a Internet Retail company, dropped about -4.82% at $39.9 in pre-market trading Monday. The firm today announced that its Board of Directors has appointed Mr. Arthur Yu, the Company’s current Vice President of Finance, as Chief Financial Officer (“CFO”), effective December 1, 2020.

    Pioneer Power Solutions Inc. (PPSI) stock moved up 10.49 percent to $4.32 in the pre-market trading.

    SPI Energy Co. Ltd. (SPI) gained over 8.79% at $10.4 in pre-market trading Monday November 23, 2020.

    Bio-Path Holdings Inc. (BPTH) is down more than -0.54% at $3.65 in pre-market hours Monday November 23, 2020 as a result of announcement that the enrollment and dosing of the first patient in a Phase 1 clinical trial evaluating the ability of BP1002 to treat refractory/relapsed lymphoma and chronic lymphocytic leukemia (CLL) patients. The stock had jumped over 9.88% to $3.67 in the last trading session.

    Before the trading started on November 23, 2020, Fuel Tech Inc. (FTEK) is up 19.69% to reach $1.52. It has been trading in a 52-week range of $0.30 to $2.05.

    Medigus Ltd. (MDGS) stock soared 8.48% to $3.07 in the pre-market trading after the firm announced its intention to enter into the electric vehicle and electric charging markets. Medigus signed a non-binding memorandum of understanding with the founders of EMuze to invest in a joint venture, NewCo, for the commercialization of EV micro-mobility vehicles for individual urban use, “last mile” and cargo delivery.

    GreenPower Motor Company Inc. (NASDAQ: GP) shares are trading up 11.34% at $24.54 at the time of writing as the news appeared that the Company has granted an aggregate of 300,000 incentive stock options with 100,000 stock options to each of Brendan Riley, Michael Sieffert and Fraser Atkinson. The stock options are subject to the approval of the TSX Venture Exchange and are exercisable for a period of five years at a price of US $20 per share. Company’s 52-week ranged between $0.82 to $23.45. Analysts have a consensus price target of $22.

    Check-Cap Ltd. (CHEK) grew over 7.1% at $0.38 in pre-market trading today.

    Mesoblast Limited (MESO), a Biotechnology company, rose about 9.8% at $15.13 in pre-market trading Monday after announcement of financial results for the third quarter and nine months ended September 30, 2020

    Titan Pharmaceuticals Inc. (TTNP) stock moved down -5.62 percent to $0.193 in the pre-market trading.

    The9 Limited (NCTY) gained over 21.45% at $3.68 in pre-market trading Monday November 23, 2020 as the company revealed that it will hold its annual general meeting of shareholders at the 17 Floor, No. 130 Wu Song Road, Hong Kou District, Shanghai 200080, People’s Republic of China on December 22, 2020 at 2:00 p.m., Shanghai time.

    Before the trading started on November 23, 2020, CPS Technologies Corporation (CPSH) is up 30.0% to reach $3.12. It has been trading in a 52-week range of $0.88 to $3.35.

    Canaan Inc. (CAN) stock soared 17.52% to $5.03 in the pre-market trading following the company plans to release its third quarter 2020 financial results before the market opens on Monday, November 30, 2020.

    Ferroglobe PLC (GSM), a Other Industrial Metals & Mining company, rose about 24.46% at $1.16 in pre-market trading Monday.

    Ideanomics Inc. (IDEX) stock moved up 37.01 percent to $2.11 in the pre-market trading after the company announced that it has increased its stake in California-based Solectrac, Inc. through a follow-on investment of an additional $1.3 million.